Evidence map›Paper›PMID 26544187›Full record

ArticlePloS one2015

p31comet-Induced Cell Death Is Mediated by Binding and Inactivation of Mad2.

Hyun-Jin Shin, Eun-Ran Park, Sun-Hee Yun, Su-Hyeon Kim, Won-Hee Jung, Seon Rang Woo, Hyun-Yoo Joo, Su Hwa Jang, Hee Yong Chung, Sung Hee Hong and 4 more

Open access · goldAbstract read
In one paragraph

Article in PloS one, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
0.2field-weighted citation impact, top 45% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 4 citations in OpenAlex.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors at 5 institutions in 1 country.

Hyun-Jin ShinDivision of Radiation Cancer Research, Korea Institute of Radiological & Medical Sciences, Seoul 139-706, Korea.
Eun-Ran ParkDivision of Radiation Cancer Research, Korea Institute of Radiological & Medical Sciences, Seoul 139-706, Korea.
Sun-Hee YunDivision of Radiation Cancer Research, Korea Institute of Radiological & Medical Sciences, Seoul 139-706, Korea.
Su-Hyeon KimDivision of Radiation Cancer Research, Korea Institute of Radiological & Medical Sciences, Seoul 139-706, Korea.
Won-Hee JungDivision of Radiation Cancer Research, Korea Institute of Radiological & Medical Sciences, Seoul 139-706, Korea.
Seon Rang WooDivision of Radiation Cancer Research, Korea Institute of Radiological & Medical Sciences, Seoul 139-706, Korea.
Hyun-Yoo JooDivision of Radiation Cancer Research, Korea Institute of Radiological & Medical Sciences, Seoul 139-706, Korea.
Su Hwa JangGraduate School of Biomedical Science and Engineering, Hanyang University, Seoul 133-791, Korea.
Hee Yong ChungGraduate School of Biomedical Science and Engineering, Hanyang University, Seoul 133-791, Korea.
Sung Hee HongDivision of Radiation Cancer Research, Korea Institute of Radiological & Medical Sciences, Seoul 139-706, Korea.
Myung-Haing ChoLaboratory of Toxicology, College of Veterinary Medicine, Seoul National University, Seoul 151-74-2, Korea.
Joong-Jean ParkDepartment of Physiology, College of Medicine, Korea University, Seoul 136-705, Korea.
Miyong YunDivision of Radiation Cancer Research, Korea Institute of Radiological & Medical Sciences, Seoul 139-706, Korea.
Kee-Ho LeeDivision of Radiation Cancer Research, Korea Institute of Radiological & Medical Sciences, Seoul 139-706, Korea.
Korea Institute of Radiological and Medical Sciences · KRHanyang University · KRKorea University · KRSeoul National University · KRYonsei University · KR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Mad2, a key component of the spindle checkpoint, is closely associated with chromosomal instability and poor prognosis in cancer. p31comet is a Mad2-interacting protein that serves as a spindle checkpoint silencer at mitosis. In this study, we showed that p31comet-induced apoptosis and senescence occur via counteraction of Mad2 activity. Upon retroviral transduction of p31comet, the majority of human cancer cell lines tested lost the ability to form colonies in a low-density seeding assay. Cancer cells with p31comet overexpression underwent distinct apoptosis and/or senescence, irrespective of p53 status, confirming the cytotoxicity of p31comet. Interestingly, both cytotoxic and Mad2 binding activities were eliminated upon deletion of the C-terminal 30 amino acids of p31comet. Point mutation or deletion of the region affecting Mad2 binding additionally abolished cytotoxic activity. Consistently, wild-type Mad2 interacting with p31comet, but not its non-binding mutant, inhibited cell death, indicating that the mechanism of p31comet-induced cell death involves Mad2 inactivation. Our results clearly suggest that the regions of p31comet affecting interactions with Mad2, including the C-terminus, are essential for induction of cell death. The finding that p31comet-induced cell death is mediated by interactions with Mad2 that lead to its inactivation is potentially applicable in anticancer therapy.

Indexed as

ApoptosisAdaptor Proteins, Signal TransducingAnimalsCell Cycle ProteinsCell Line, TumorCell SurvivalCellular SenescenceClone CellsHumansMad2 ProteinsMiceM Phase Cell Cycle CheckpointsNuclear ProteinsProtein BindingSequence DeletionAdaptor Proteins, Signal TransducingCell Cycle ProteinsMAD2L1BP protein, humanMad2 ProteinsNuclear Proteins

Identifiers

PMID26544187
PMCPMC4636321
OpenAlexW2236482534

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.